DENG Dongjie,LI Li,WANG Chuting,et al.Effect and Mechanism of Osthole on Proliferation and Apoptosis in Human Intrahepatic Cholangiocarcinoma HuCCT1 Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):54-60.
DENG Dongjie,LI Li,WANG Chuting,et al.Effect and Mechanism of Osthole on Proliferation and Apoptosis in Human Intrahepatic Cholangiocarcinoma HuCCT1 Cells[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(20):54-60. DOI: 10.13422/j.cnki.syfjx.20222423.
Effect and Mechanism of Osthole on Proliferation and Apoptosis in Human Intrahepatic Cholangiocarcinoma HuCCT1 Cells
To investigate the effect and mechanism of osthole on the proliferation and apoptosis in human intrahepatic cholangiocarcinoma HuCCT1 cells.
Method
2
The effect of 10, 20, 40, 80, and 120 μmol·L
-1
osthole on the proliferation of HuCCT1 cells was detected by the cell counting kit-8 (CCK-8). A blank group, and low-, medium-, and high-dose osthole groups (16, 32, and 64 μmol·L
-1
) were set up. The effect of osthole on cell clone formation rate was detected by colony formation assay. The effect of osthole on cell cycle and apoptosis was detected by flow cytometry. The effect of osthole on cell apoptotic morphology was detected by Hoechst 33342 fluorescent staining. The effect of osthole on cell cycle protein cyclin B
1
, proliferating cell nuclear antigen (PCNA), cysteine-aspartic acid protease (Caspase)-9, Caspase-3, cleaved Caspase-9, cleaved Caspase-3, cleaved poly(ADP-ribose) polymerase (cleaved PARP), B-cell lymphoma-2 (Bcl-2), phosphorylated protein kinase B (p-Akt), phosphorylated mammalian target of rapamycin (p-mTOR), and phosphorylated ribosomal protein S6 (p-RPS6) was detected by Western blot.
Result
2
The cell viability in the osthole group(40,80,120 μmol·L
-1
) decreased (
P
<
0.05,
P
<
0.01), with the half maximal inhibitory concentration (IC
50
) of 63.8 μmol·L
-1
as compared with that in the blank group. Compared with the blank group, the osthole groups(32,64 μmol·L
-1
)showed reduced clone formation rate (
P
<
0.01), increased number of cells in the G
2
phase (
P
<
0.05,
P
<
0.01), decreased number of cells, increased pyknosis and fragmentation, increased apoptosis rate (
P
<
0.05,
P
<
0.01), down-regulated expression of cyclin B
1
, PCNA, Bcl-2, Caspase-3, Caspase-9, p-Akt, p-mTOR, and p-RPS6 (
P
<
0.05,
P
<
0.01), and up-regulated expression of cleaved Caspase-3, cleaved Caspase-9, and cleaved PARP
(
P
<
0.05,
P
<
0.01).
Conclusion
2
Osthole can inhibit the proliferation and promote the apoptosis of HuCCT1 cells, and its mechanism may be related to the Akt/mTOR signaling pathway.
关键词
蛇床子素肝内胆管癌增殖凋亡蛋白激酶B/哺乳动物雷帕霉素靶蛋白
Keywords
ostholeintrahepatic cholangiocarcinomaproliferationapoptosisprotein kinase B/mammalian target of rapamycin
references
SIRICA A E, GORES G J, GROOPMAN J D, et al. Intrahepatic cholangiocarcinoma: Continuing challenges and translational advances[J]. Hepatology, 2019,69(4):1803-1815.
WIRTH T C, VOGEL A. Surveillance in cholangiocellular carcinoma[J]. Best Pract Res Clin Gastroenterol, 2016,30(6):987-999.
JARZAB A, GRABARSKA A, SKALICKA-WOZNIAK K, et al. Pharmacological features of osthole[J]. Postepy Hig Med Dosw (Online), 2017,71:411-421.
JIANG G, LIU J, REN B, et al. Anti-tumor effects of osthole on ovarian cancer cells in vitro[J]. J Ethnopharmacol, 2016,193:368-376.
WANG L, PENG Y, SHI K, et al. Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis[J]. J Biomed Res, 2015,29(2):132-138.
MO Y, WU Y, LI X, et al. Osthole delays hepatocarcinogenesis in mice by suppressing Akt/FASN axis and ERK phosphorylation[J]. Eur J Pharmacol, 2020, doi:10.1016/j.ejphar.2019.172788http://dx.doi.org/10.1016/j.ejphar.2019.172788.
ZHU X, SONG X, XIE K, et al. Osthole induces apoptosis and suppresses proliferation via the PI3K/Akt pathway in intrahepatic cholangiocarcinoma[J]. Int J Mol Med, 2017,40(4):1143-1151.
CROWLEY L C, MARFELL B J, WATERHOUSE N J. Analyzing cell death by nuclear staining with Hoechst 33342[J]. Cold Spring Harb Protoc, 2016, doi:10.1101/pdb.prot087205http://dx.doi.org/10.1101/pdb.prot087205.
STRZALKA W, ZIEMIENOWICZ A. Proliferating cell nuclear antigen (PCNA): A key factor in DNA replication and cell cycle regulation[J]. Ann Bot, 2011,107(7):1127-1140.
REYES-LAMOTHE R, SHERRATT D J. The bacterial cell cycle, chromosome inheritance and cell growth[J]. Nat Rev Microbiol, 2019,17(8):467-478.
KONG M,BARNES E A,OLLENDORFF V,et al.Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction[J].EMBO J,2000,19(6):1378-1388.
EVAN G I, VOUSDEN K H. Proliferation, cell cycle and apoptosis in cancer[J]. Nature, 2001,411(6835):342-348.
LIN W, XIE J, XU N, et al. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells[J]. Int J Biol Sci, 2018,14(4):418-426.
ENGELMAN J A, LUO J, CANTLEY L C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism[J]. Nat Rev Genet, 2006,7(8):606-619.
LIN V C, CHOU C H, LIN Y C, et al. Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway[J]. J Agric Food Chem, 2010,58(8):4786-4793.
LV X, YANG H, ZHONG H, et al. Osthole exhibits an antitumor effect in retinoblastoma through inhibiting the PI3K/Akt/mTOR pathway via regulating the hsa_circ_0007534/miR-214-3p axis[J]. Pharm Biol, 2022,60(1):417-426.
Yangyin Huayu Jiedu Preseription Regulates Autophagy and Apoptosis of Colon Cancer Cells in Hypoxic Environment Through PI3K/Akt Signaling Pathway
Effect of Ursolic Acid on Proliferation and Apoptosis of Colorectal Cancer Cells Based on Akt/FoxO Signaling Pathway
Effect of Qiling Baitouweng Tang on Proliferation and Apoptosis in Diffuse Large B-cell Lymphoma Through JAK2/STAT3 Signaling Pathway
Effect of Modified Huangqi Gancaotang on Proliferation, Apoptosis, Invasion, Migration, and Epithelial-mesenchymal Transition of Non-small Cell Lung Cancer Cells Based on Wnt/β-catenin Pathway
Related Author
CHEN Xuan
LIU Hongning
SHANG Guangbin
LIU Ge
HU Jia
ZHANG Zhongkang
YAN Xiaojun
ZHENG Qiao
Related Institution
Research Center for Differentiation and Development of Traditional Chinese Medicine (TCM) Basic Theory, Jiangxi University of Chinese Medicine/Jiangxi Province Key Laboratory of TCM Etiopathogenisis
Traditional Chinese Medicine(TCM)Regulating Metabolic Diseases Key Laboratory of Sichuan Province,Hospital of Chengdu University of TCM
State Key Laboratory of Ultrasound in Medical and Engineering,Chongqing Medical University
The First School of Clinical Medicine of Nanjing University of Chinese Medicine
Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine